CR vs PH: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CR and PH share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CR and PH exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Crane Company became a standalone public company in April 2023 when Crane Holdings separated into two businesses, with the industrial operations listing as CR (the payments-and-authentication side became Crane NXT). The company runs two segments: Aerospace & Advanced Technologies, which supplies power conversion, actuation, sensing and thermal-management systems for commercial aircraft, military platforms and space, and Process Flow Technologies, which makes valves, pumps, instrumentation and cryogenic systems for chemical, pharmaceutical, water and energy customers.

Full CR guide

Parker Hannifin makes motion and control technologies: hydraulics, pneumatics, filtration, sealing and electromechanical systems used across industrial machinery and aerospace. Its customers range from machine builders, mobile equipment makers and process industries to commercial and defence aircraft programs, and a large share of revenue comes from replacement parts and aftermarket service on equipment already in the field.

Full PH guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CR drivers: Aerospace and defense demand; Process Flow Technologies and cryogenics.
• PH drivers: Aerospace is now a major earnings engine; Aftermarket and replacement demand.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Crane trades at a premium valuation (about 36 times trailing and 26 times forward earnings in October 2026), so any slowdown in growth or margin misstep could pressure the stock. For PH, industrial demand is cyclical and tracks capital spending, manufacturing output and construction.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CR if you believe its drivers more; PH if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CR and PH guides.

CR. Crane has beaten adjusted EPS estimates in each of the last four reported quarters, and analysts expect full-year 2026 EPS near $7.02 rising to about $7.84 in 2027. The gap between a trailing multiple near 36 times and a forward multiple near 26 times shows how much of the valuation rests on that growth arriving, partly through acquisition charges rolling off. The ten covering analysts carry a mean target near $237 and a strong-buy consensus, while the shares sit about 10% under their 52-week high.

PH. Parker is a diversified industrial whose story in recent years has been margin expansion and the aerospace mix shift rather than rapid revenue growth. At $965.76 in mid-October 2026 the market pays about 24 times forward earnings for that record, with consensus calling for fiscal 2027 EPS of about $35.52 on revenue near $24.7 billion. The fiscal Q1 2027 report, expected around November 5 with consensus EPS of about $8.17, is the next check on whether 5.5-8.5% sales growth guidance holds.

Headline figures (approximate, October 2026): CR shows revenue (ttm) ~$2.59B, revenue growth (q2 2026) ~26% YoY, including acquisitions, adjusted eps (q2 2026) ~$1.79 vs ~$1.68 consensus, net income (ttm) ~$336M, a profit margin near ~13%; PH shows revenue (fiscal 2026) ~$21.5 billion, +9.8% yoy in the June quarter, net income (fiscal 2026) ~$3.65 billion (~17% net margin, ~23% operating margin), eps (q4 fy2026 vs estimate) $9.27 vs ~$8.27 (adjusted), p/e (trailing / forward) ~34x / ~24x.

CR and PH are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CR and PH exposure against your real portfolio. It is not an investment adviser.